Gsk (GSK) EV to EBITDA (2009 - 2026)
Gsk's (GSK) EV to EBITDA stood at 10.92 in the quarter ended Sep 8, 2026.
Powered by 
Analysis
Gsk (GSK) EV to EBITDA (2009 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Gsk's EV to EBITDA came in at 6.52, down 13.0% from the prior year.
- Across earlier years, EV to EBITDA came in at 7.49 in the year ended Dec 31, 2024 (+18.6%), 6.32 in the year ended Dec 31, 2023 (-13.8%), 7.33 in the year ended Dec 31, 2022 (-43.7%) and 13.02 in the year ended Dec 31, 2021 (+6.0%).
- The figure for the quarter ended Sep 8, 2026 is the lowest quarterly EV to EBITDA since the quarter ended Mar 31, 2025.
- On a year-over-year basis, EV to EBITDA rose in three of the last four quarters, with growth averaging 63.0%.
- Peak year-over-year performance for EV to EBITDA in the last five years was growth of 137.1% in the quarter ended Dec 31, 2025, against a decline of 24.1% in the quarter ended Dec 31, 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn |
| 10 | Gsk | 100.33 Bn | 81.91 Bn | 8.24 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 15.22 |
| Dec 31, 2025 | 15.86 |
| Mar 31, 2025 | 7.31 |
| Dec 31, 2024 | 6.69 |
| Mar 31, 2024 | 8.58 |
| Dec 31, 2023 | 6.67 |
| Mar 31, 2023 | 6.98 |
| Dec 31, 2022 | 7.65 |
| Mar 31, 2022 | 13.92 |
| Dec 31, 2021 | 14.98 |
| Mar 31, 2021 | 9.38 |
| Dec 31, 2020 | 8.32 |
| Mar 31, 2020 | 6.68 |
| Dec 31, 2019 | 8.28 |
| Sep 30, 2019 | 7.96 |
| Mar 31, 2019 | 8.03 |
| Dec 31, 2018 | 9.02 |
| Mar 31, 2018 | 11.12 |
| Dec 31, 2017 | 3.96 |
| Mar 31, 2017 | 2.82 |
API Access
Gsk EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();